Chiltern International and Charles River Laboratories have entered into a collaboration under which Chiltern Early Phase will partner with Charles River to conduct and support radiolabelled studies. Glenn Kerkhof, Chiltern’s chief executive officer, stated, “This new partnership is an exciting collaboration. Charles River’s reputation is world-renowned for their conduct of studies using radiolabelled investigational products. Chiltern Early Phase in Dundee, Scotland will perform the clinical ...